Specific Adverse Effects Reported in Clinical Trials While the overall safety profile was excellent, clinical trials documented all adverse events regardless of severity or causality
Cash-pay, varying widely by market, usually priced per injection or bundled into a programme
CIs were not adjusted for multiplicity and should therefore not be used to infer definitive treatment effects
No statistically significant increases in chromosomal aberrations were observed in CHO cells at any tested concentration
This type of study is important for several reasons: it tells us how long the peptide remains active in the body, what breakdown products are formed (which could themselves have biological activity or be used as markers in drug testing), and helps explain why AOD9604 needs to be administered in certain ways to remain effective
Sources Ready to explore peptide therapy for weight loss in Stamford, CT